RT Journal Article
SR Electronic
T1 Estimating the effects of non-pharmaceutical interventions on the number of new infections with COVID-19 during the first epidemic wave
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.01.15.21249884
DO 10.1101/2021.01.15.21249884
A1 Nicolas Banholzer
A1 Eva van Weenen
A1 Adrian Lison
A1 Alberto Cenedese
A1 Arne Seeliger
A1 Bernhard Kratzwald
A1 Daniel Tschernutter
A1 Joan Puig Salles
A1 Pierluigi Bottrighi
A1 Sonja Lehtinen
A1 Stefan Feuerriegel
A1 Werner Vach
YR 2021
UL http://medrxiv.org/content/early/2021/01/20/2021.01.15.21249884.abstract
AB The novel coronavirus (SARS-CoV-2) has rapidly developed into a global epidemic. To control its spread, countries have implemented non-pharmaceutical interventions (NPIs), such as school closures, gathering bans, or even stay-at-home orders. Here we study the effectiveness of seven NPIs in reducing the number of new infections, which was inferred from the reported cases of COVID-19 using a semi-mechanistic Bayesian hierarchical model. Based on data from the first epidemic wave of n = 20 countries (i.e., the United States, Canada, Australia, the EU-15 countries, Norway, and Switzerland), we estimate the relative reduction in the number of new infections attributed to each NPI. Among the NPIs considered, event bans were most effective, followed by venue and school closures, whereas stay-at-home orders and work bans were least effective. With this retrospective cross-country analysis, we provide estimates regarding the effectiveness of different NPIs during the first epidemic wave.Competing Interest StatementSF reports membership in a COVID-19 working group of the World Health Organization but without competing interest. JPS declares part-time employment at Luciole Medical outside of the submitted work. SF reports grants from the Swiss National Science Foundation outside of the submitted work. All other authors declare no competing interests.Funding StatementNB, EvW and SF acknowledge funding from the Swiss National Science Foundation (SNSF) as part of the Eccellenza grant 186932 on "Data-driven health management". The funding bodies had no control over design, conduct, data, analysis, review, reporting, or interpretation of the research conducted.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesWe collected data from publicly available data sources (Johns Hopkins Coronavirus Resource Center for epidemiological data; news reports and government resources for policy measures). All the public health information that we used is documented in the main text, the extended data, and supplementary tables. A preprocessed data file together with reproducible code is available from https://github.com/nbanho/npi_effectiveness_first_wave. https://github.com/nbanho/npi_effectiveness_first_wave